Catalyst Wire Dossier Catalyst Wire Dossier

WEGOVY

Semaglutide · Novo Nordisk
Drug timelines are a Plus or Pro feature.

54 regulatory and trial events tracked for WEGOVY, covering 2021-06-04 to 2026-08-26. Get the full timeline:

Most recent: EMA Authorised: Wegovy (semaglutide) — Novo Nordisk A/S

See pricing